光子計數 CT 市場機會、成長要素、產業趨勢分析及 2026-2035 年預測。

全球光子計數 CT 市場預計到 2025 年將達到 3.227 億美元，年複合成長率為 24.7%，到 2035 年將達到 29 億美元。

隨著醫療專業人員對能夠提供更高診斷準確性和改善患者預後的先進影像技術的需求日益成長，光子計數CT市場正經歷快速成長。慢性病和癌症發生率的上升，以及對高品質診斷影像需求的不斷成長，正在加速下一代電腦斷層掃描（CT）解決方案的普及。光子計數CT系統利用先進的檢測器技術捕捉單一X光光子並測量其能量水平，與傳統CT系統相比，能夠進行更精細的影像分析。這些系統整合了基於半導體的檢測器、先進的運算平台和複雜的重建軟體，從而提供更高的影像清晰度、更強的組織識別能力、更低的雜訊和更小的輻射暴露。臨床上對更精確的疾病檢測日益成長的需求，正在推動包括腫瘤學、心血管成像、神經系統評估、肌肉骨骼評估和肺部疾病診斷在內的眾多醫學領域的應用。隨著醫院和影像中心不斷升級其診斷基礎設施，對光子計數CT技術的需求預計將持續成長。人們越來越重視早期診斷、個人化治療方案製定和提高成像效率，這為光子計數 CT 市場創造了強勁的成長機會。

到2025年，獨立式光子計數CT系統將佔據最大的市場佔有率，達到87.9%。這一主導地位得益於專用光子計數CT掃描儀的日益普及，這些掃描儀旨在最大限度地發揮先進檢測器技術的優勢。與傳統CT平台相比，這些系統可提供更高的影像品質、更優的頻譜成像性能、更高的空間解析度和更低的輻射暴露。其整合式設計最佳化了系統功能並增強了臨床應用能力，使其成為投資先進診斷影像解決方案的醫療機構的首選。

預計到2025年，碲化鎘（CdTe）檢測器將佔據85.1%的市佔率。 CdTe檢測器憑藉其在商用光子計數CT系統中的廣泛應用以及直接將X光光子轉換為電訊號的能力，已確立了其穩固的地位。與傳統檢測器技術相比，該技術能夠提高影像解析度、增強頻譜成像能力、降低電子雜訊並提高劑量效率。 CdTe檢測器久經考驗的卓越性能及其與先進CT平台的整合，持續推動其在醫療領域的應用。

到2025年，北美光子計數CT市場佔有率將達到38%。此區域擴張的驅動力包括：對先進診斷影像解決方案的需求不斷成長、慢性病患病率上升以及醫療機構對創新CT技術的廣泛應用。先進的醫療基礎設施、對醫學影像技術投資的增加以及對精準疾病檢測的日益重視，都促進了北美光子計數CT市場的持續成長。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

• 產業生態系分析
• 影響產業的因素
  • 促進因素
    • 對高解析度診斷成像的需求日益成長。
    • 慢性病和癌症發生率增加
    • 醫療機構中先進CT技術的應用範圍擴大
    • 檢測器材料和系統設計的技術進步
  • 產業潛在風險與挑戰
    • 安裝和設備成本高昂
    • 光子計數CT系統的供應有限。
    • 缺乏能夠勝任操作和翻譯工作的專業人員。
  • 機會
    • 新興醫療保健市場的擴張
    • 增加研發投資
    • 精準醫療和個人化醫療正變得越來越普及。
• 成長潛力分析
• 監理情勢
• 價格趨勢分析
• 專利分析
• 技術與創新展望
  • 最新科技趨勢
  • 新興技術
• 未來市場趨勢
• 人工智慧和生成式人工智慧對市場的影響
• 波特的分析
• PESTLE分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係和聯盟
  • 新產品發布
  • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

• 獨立式光子計數CT系統
• 針對現有設備的改造型光子計數CT解決方案

第6章 市場估算與預測：依檢測器類型分類，2022-2035年

• 矽檢測器
• 碲化鎘檢測器
• 碲化鎘鋅 (CZT)檢測器
• 其他檢測器類型

第7章 市場估計與預測：依應用領域分類，2022-2035年

• 腫瘤學
• 循環系統
• 神經病學
• 整形外科
• 呼吸內科
• 其他用途

第8章 市場估算與預測：依通路分類，2022-2035年

• 實體店面
• 電子商務

第9章 市場估價與預測：依最終用戶分類，2022-2035年

• 醫院
• 診斷影像中心
• 研究機構
• 其他最終用戶

第10章 市場估價與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • UAE

第11章：公司簡介

• Canon
• GE HealthCare
• Kromek
• Neusoft Medical Systems
• PHILIPS
• Samsung
• Siemens Healthineers
• United Imaging Healthcare

The Global Photon-Counting CT Market was valued at USD 322.7 million in 2025 and is estimated to grow at a CAGR of 24.7% to reach USD 2.9 billion by 2035.

The photon-counting CT market is experiencing rapid expansion as healthcare providers increasingly seek advanced imaging technologies that deliver greater diagnostic precision and improved patient outcomes. The rising incidence of chronic diseases and cancer, combined with growing demand for high-quality diagnostic imaging, is accelerating the adoption of next-generation computed tomography solutions. Photon-counting CT systems use advanced detector technology to capture individual X-ray photons and measure their energy levels, enabling more detailed image analysis compared with traditional CT systems. These systems integrate semiconductor-based detectors, advanced computing platforms, and sophisticated reconstruction software to provide enhanced image clarity, improved tissue differentiation, reduced noise, and lower radiation exposure. Increasing clinical interest in more accurate disease detection is supporting adoption across multiple medical applications, including oncology, cardiovascular imaging, neurological assessment, musculoskeletal evaluation, and pulmonary diagnostics. As hospitals and imaging centers continue upgrading their diagnostic infrastructure, demand for photon-counting CT technology is expected to rise. The growing focus on early diagnosis, personalized treatment planning, and improved imaging efficiency is creating strong growth opportunities for the photon-counting CT market.

The standalone photon-counting CT systems segment held the largest market share of 87.9% in 2025. The segment's leadership is supported by increasing adoption of dedicated photon-counting CT scanners designed to maximize the advantages of advanced detector technology. These systems provide improved image quality, enhanced spectral imaging performance, higher spatial resolution, and reduced radiation exposure compared with conventional CT platforms. Their integrated design enables optimized system functionality and improved clinical capabilities, making them a preferred choice among healthcare providers investing in advanced diagnostic imaging solutions.

The cadmium telluride (CdTe) detectors segment accounted for 85.1% share in 2025. The strong position of CdTe detectors is attributed to their extensive use in commercially available photon-counting CT systems and their ability to directly transform X-ray photons into electrical signals. This technology supports improved image resolution, stronger spectral imaging capabilities, lower electronic noise, and enhanced dose efficiency compared with conventional detector technologies. The established performance of CdTe detectors and their integration into advanced CT platforms continue to drive adoption across healthcare institutions.

North America Photon-Counting CT Market accounted for 38% share in 2025. Regional expansion is supported by increasing demand for advanced diagnostic imaging solutions, rising prevalence of chronic conditions, and growing adoption of innovative CT technologies across healthcare facilities. The presence of advanced healthcare infrastructure, higher investment in medical imaging technologies, and increasing focus on accurate disease detection are contributing to the continued development of the photon-counting CT market in North America.

Prominent companies operating in the Global Photon-Counting CT Market include Siemens Healthineers, Canon, GE HealthCare, Kromek, Neusoft Medical Systems, PHILIPS, Samsung, and United Imaging Healthcare. Companies operating in the photon-counting CT market are strengthening their competitive position through continuous innovation, strategic partnerships, and investments in advanced imaging technologies. Industry participants are focusing on improving detector performance, enhancing image reconstruction capabilities, and expanding clinical applications to increase adoption. Companies are also investing in research and development activities to improve system efficiency, reduce operational limitations, and support broader healthcare implementation. Strategic collaborations with hospitals, research organizations, and healthcare providers are helping manufacturers strengthen their market presence and accelerate technology adoption. In addition, businesses are expanding product portfolios, improving customer support services, and developing advanced solutions to address the growing demand for precise, low-dose, and high-resolution diagnostic imaging systems.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Detector type trends
  • 2.2.4 Application trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing demand for high-resolution diagnostic imaging
    • 3.2.1.2 Increasing prevalence of chronic diseases and cancer
    • 3.2.1.3 Rising adoption of advanced CT technologies in healthcare facilities
    • 3.2.1.4 Technological advancements in detector materials and system design
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High installation and equipment costs
    • 3.2.2.2 Limited availability of photon-counting CT systems
    • 3.2.2.3 Shortage of trained professionals for operation and interpretation
  • 3.2.3 Opportunities
    • 3.2.3.1 Expansion in emerging healthcare markets
    • 3.2.3.2 Increasing research and development investments
    • 3.2.3.3 Growing adoption in precision medicine and personalized healthcare
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Pricing trend analysis
• 3.6 Patent analysis
• 3.7 Technology and innovation landscape (Driven by Primary Research)
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Future market trends (Driven by Primary Research)
• 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Standalone photon-counting CT systems
• 5.3 Retrofit photon-counting CT solutions

Chapter 6 Market Estimates and Forecast, By Detector Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Silicon detectors
• 6.3 Cadmium telluride detectors
• 6.4 Cadmium zinc telluride (CZT) detectors
• 6.5 Others detector types

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Oncology
• 7.3 Cardiology
• 7.4 Neurology
• 7.5 Orthopedics
• 7.6 Pulmonology
• 7.7 Other application

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Brick and mortar stores
• 8.3 E-commerce

Chapter 9 Market Estimates and Forecast, By End User, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 Hospital
• 9.3 Diagnostic Imaging Centers
• 9.4 Research Institutes
• 9.5 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 MEA
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Canon
• 11.2 GE HealthCare
• 11.3 Kromek
• 11.4 Neusoft Medical Systems
• 11.5 PHILIPS
• 11.6 Samsung
• 11.7 Siemens Healthineers
• 11.8 United Imaging Healthcare